Manganese distribution across the blood-brain barrier. II. Manganese efflux from the brain does not appear to be carrier mediated

NeuroToxicology

Volumn 24, Issue 1, 2003, Pages 15-22

  Yokel, Robert A ^a   Crossgrove, Janelle S ^a   Bukaveckas, Bonny L ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Blood brain barrier; Brain efflux; Manganese; Rat; Transport kinetics

Indexed keywords

CARBON 14; DEXTRAN; MANGANESE; MANGANESE CITRATE; MANGANESE PHOSPHATE; MANGANESE TRANSFERRIN; SUCROSE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN SLICE; CALCULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFUSION; EXTRACELLULAR FLUID; FLOW KINETICS; INJECTION; ION TRANSPORT; MEMBRANE TRANSPORT; NEUROTOXICITY; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; RAT; THERMODYNAMICS;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CITRIC ACID; MANGANESE; RATS; RATS, SPRAGUE-DAWLEY; TRANSFERRIN;

EID: 0037231207     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-813X(02)00090-6     Document Type: Article

References (37)

1. a v5.0 was obtained using the ACD/I-Lab service. ACD Inc., 2002.
2. Asaba H, Hosoya K, Takanaga H, Ohtsuki S, Tamura E, Takizawa T, et al. Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2. J Neurochem 2000; 75:1907-16.
3. Aschner M, Vrana KE, Zheng W. Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology 1999;20:173-80.
4. Bradbury MW. Transport of iron in the blood-brain-cerebrospinal fluid system. J Neurochem 1997;69:443-54.
5. Comford EM, Diep CP, Pardridge WM. Blood-brain barrier transport of valproic acid. J Neurochem 1985;44:1541-50.
6. Cotton FA, Wilkinson G. Advanced inorganic chemistry. New York: Wiley; 1980. p. 741-3.
7. Crossgrove JS, Allen DD, Bukaveckas BL, Rhineheimer SS, Yokel RA. Manganese distribution across the blood-brain barrier. I. Evidence for carrier-mediated influx of manganese citrate as well as manganese and manganese transferrin. Neurotoxicology, 2003;24:3-13.
8. Deguchi Y, Morimoto K. Application of an in vivo brain microdialysis technique to studies of drug transport across the blood-brain barrier. Curr Drug Metab 2001;2:411-23.
9. Festa M, Colonna A, Pietropaolo C, Ruffo A. Oxalomalate, a competitive inhibitor of aconitase, modulates the RNA-binding activity of iron-regulatory proteins. Biochem J 2000;348(Part 2):315-20.
10. Gianutsos G, Seltzer MD, Saymeh R, Wu ML, Michel RG. Brain manganese accumulation following systemic administration of different forms. Arch Toxicol 1985;57:272-5.
11. Hosoya K, Asaba H, Terasaki T. Brain-to-blood efflux transport of estrone-3-sulfate at the blood-brain barrier in rats. Life Sci 2000;67:2699-711.
12. Hosoya K, Sugawara M, Asaba H, Terasaki T. Blood-brain barrier produces significant efflux of L-aspartic acid but not D-aspartic acid: in vivo evidence using the brain efflux index method. J Neurochem 1999;73:1206-11.
13. Huang JD. Comparative drug exsorption in the perfused rat intestine. J Pharm Pharmacol 1990;42:167-70.
14. Huwyler J, Pardridge WM. Examination of blood-brain barrier transferrin receptor by confocal fluorescent microscopy of unfixed isolated rat brain capillaries. J Neurochem 1998;70: 883-6.
15. Kakee A, Takanaga H, Terasaki T, Naito M, Tsuruo T, Sugiyama Y. Efflux of a suppressive neurotransmitter, GABA, across the blood-brain barrier. J Neurochem 2001;79:110-8.
16. Kakee A, Terasaki T, Sugiyama Y. Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier. J Pharmacol Exp Ther 1996;277:1550-9.
17. Kakee A, Terasaki T, Sugiyama Y. Selective brain to blood efflux transport of para-aminohippuric acid across the blood-brain barrier: in vivo evidence by use of the brain efflux index method. J Pharmacol Exp Ther 1997;283:1018-25.
18. Kitazawa T, Terasaki T, Suzuki H, Kakee A, Sugiyama Y. Efflux of taurocholic acid across the blood-brain barrier: interaction with cyclic peptides. J Pharmacol Exp Ther 1998;286: 890-5.
19. Kusuhara H, Suzuki H, Terasaki T, Kakee A, Lemaire M, Sugiyama Y. p-Glycoprotein mediates the efflux of quinidine across the blood-brain barrier. J Pharmacol Exp Ther 1997;283:574-80.
20. Lee VHL, Carson W, Takemoto KA. Macromolecular drug absorption in the albino rabbit eye. Int J Pharm 1986;29:43-51.
21. Leininger B, Ghersi-Egea JF, Siest G, Minn A. In vivo study of the elimination from rat brain of an intracerebrally formed xenobiotic metabolite, 1-naphthyl-β-D-glucuronide. J Neurochem 1991;56:1163-8.
22. Levin VA. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 1980;23:682-4.
23. Malecki EA. Limited role of transferrin in manganese transport to the brain. J Nutr 2001;131:1584-5.
24. Malecki EA, Devenyi AG, Beard JL, Connor JR. Existing and emerging mechanisms for transport of iron and manganese to the brain. J Neurosci Res 1999;56:113-22.
25. Murphy VA, Wadhwani KC, Smith QR, Rapoport SI. Saturable transport of manganese(II) across the rat blood-brain barrier. J Neurochem 1991;57:948-54.
26. Oldendorf WH, Pardridge WM, Braun LD, Crane PD. Measurement of cerebral glucose utilization using washout after carotid injection in the rat. J Neurochem 1982;38:1413-8.
27. Pavlinova AV, Shnarevich AI. The composition and the stability of the citrate compound of manganese. Zhur Neorg Khim 1960;5:2759-63.
28. Petti L, Powell K. IUPAC stability constant database. Yorks, UK: Academic Software; 1997.
29. Shinoda K, Mitsumori K, Uneyama C, Uehara M. Induction and inhibition of testicular germ cell apoptosis by fluoroacetate in rats. Arch Toxicol 2000;74:33-9.
30. Shnarevich AI. Structure of manganese(II) citrate. Zh Neorgan Khim 1963;8:2074-9.
31. Takasawa K, Terasaki T, Suzuki H, Sugiyama Y. In vivo evidence for carrier-mediated efflux transport of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system. J Pharmacol Exp Ther 1997;281:369-75.
32. Takeda A, Ishiwatari S, Okada S. Influence of transferrin on manganese uptake in rat brain. J Neurosci Res 2000;59: 542-52.
33. Wedler FC, Ley BW, Grippo AA. Manganese(II) dynamics and distribution in glial cells cultured from chick cerebral cortex. Neurochem Res 1989;14:1129-35.
34. Yokel RA. Aluminum toxicokinetics at the Blood-brain barrier. In: Exley C, editor. Aluminium and Alzheimer's disease. New York: Elsevier; 2001. p. 233-60.
35. Zhang Y, Pardridge WM. Rapid transferrin efflux from brain to blood across the blood-brain barrier. J Neurochem 2001;76: 1597-600.
36. 3H]GABA across blood-brain barrier after cerebral ischemia-reperfusion in rats. Zhongguo Yao Li Xue Bao 1999;20:223-6.
37. Zheng W, Kim H, Zhao Q. Comparative toxicokinetics of manganese chloride and methylcyclopentadienyl manganese tricarbonyl (MMT) in Sprague-Dawley rats. Toxicol Sci 2000;54:295-301.